Evaluation of Manzanilla® and Meticel Ofteno® 0.5% for Providing a Relief Sensation to the Eyes

Inclusion Criteria: * Ability to voluntarily provide signed informed consent. * Able and willing to comply with the scheduled visits, treatment plan, and other study procedures. * Be of legal age. * Women of reproductive age who have not undergone bilateral tubal ligation or hysterectomy must ensure the continued use (initiated ≥ 30 days prior to signing the - - Informed Consent Form \[ICF\]) of a hormonal contraceptive method or intrauterine device (IUD) during the study period. * A score of ≥ 3 on the analogous visual test for eye fatigue in at least 4 of the included questions. Exclusion Criteria: * Pregnant women, breastfeeding women, or those planning to become pregnant during the study period. * Having participated in another clinical research study ≤ 30 days prior to the screening visit. * Having previously participated in this study. * Having only one functional eye. * A history of current or past drug addiction or substance dependence within the last two years prior to signing the ICF. * Current user of soft or hard contact lenses. They may be included if they suspend use during the study, and they must be lens-free for 15 days prior to inclusion. * Known hypersensitivity to the components of the investigational products.